UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Current Report Pursuant to Section 13 or 15(d)
of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): October 8, 2002
Seattle Genetics, Inc.
(Exact name of Registrant as specified in its charter)
| Delaware (State or other jurisdiction of incorporation or organization) |
0-32405 (Commission File Number) |
91-1874389 (I.R.S. Employer Identification No.) |
21823 30th Drive SE, Bothell, Washington 98021
(Address of principal executive offices) (Zip Code)
(425) 527-4000
(Registrant's telephone number, including area code)
Item 7. Financial Statements and Exhibits
Item 9. Regulation FD Disclosure.
On October 8, 2002, Seattle Genetics, Inc. provided an update on the status of its SGN-14 program.
A copy of the press release containing the announcement is filed herewith as Exhibit 99.1 and is incorporated herein by this reference. This information is furnished, and not filed, pursuant to Item 9.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| SEATTLE GENETICS, INC. (Registrant) |
|||
Date: October 8, 2002 |
By: |
/s/ H. PERRY FELL H. Perry Fell Chief Executive Officer and Chairman of the Board |
|
INDEX TO EXHIBITS
| Exhibit Number |
Description |
|
|---|---|---|
99.1 |
Press Release dated October 8, 2002. |